UPNRIDE Powered Wheelchair for Individuals With Walking Impairment: Evaluation of Safety and Usability
- Conditions
- Spinal Cord Injury Cervical
- Interventions
- Device: UPnRIDE Powered Wheelchair
- Registration Number
- NCT02983955
- Lead Sponsor
- UPnRIDE Robotics Ltd.
- Brief Summary
The UPnRIDE Powered Wheelchair device is a product which changes people position from sitting to standing and standing to sitting. The product provides indoor and outdoor mobility.
The main purpose of this study is to evaluate the safety of the UPnRIDE powered wheelchair as an outdoor and indoor mobility device by individuals with walking impairment.
- Detailed Description
A new powered wheelchair has recently been developed to address the ability of the user to be able to position them in an upright, standing position. This new device is called the UPnRIDE powered wheelchair and is different from other upright wheelchairs because current standing wheelchair models have limited mobility in the standing position. The UPnRIDE is an upright or seated mobility device that is intended to provide full upright standing posture in a mobile powered wheelchair. The UPnRIDE powered wheelchair provides wheelchair and scooter users the ability to engage in society in either a standing (upright mobility) or seated position (seated mobility). Additionally, the option to have upright posture throughout the day may have the potential to improve some of the secondary medical conditions associated with the extreme sedentary lifestyle that paralysis from SCI imposes. This wheeled, motorized device can provide mobility to most urban environment situations by being able to be navigated indoors and outdoors and over different surfaces in both the standing or seated positions.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 15
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description SCI with Tetraplegia UPnRIDE Powered Wheelchair -
- Primary Outcome Measures
Name Time Method Adverse events Through study completion, an average of 3 months
- Secondary Outcome Measures
Name Time Method Successes rate of task performance Through study completion, an average of 3 months Study success is defined if 70% of study subjects are defined success
Trial Locations
- Locations (1)
The Chaim Sheba Medical Center
🇮🇱Ramat Gan, Israel